Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intensive insulin therapy: Part II. Multicomponent insulin regimens.

I B Hirsch1, C D Herter

  • 1University of Washington School of Medicine, Seattle.

American Family Physician
|June 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics of adult- compared to childhood-onset type 1 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2020
Same author

What is innovation in the area of medicines? The example of insulin and diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2019
Same author

Associations between HbA<sub>1c</sub> and continuous glucose monitoring-derived glycaemic variables.

Diabetic medicine : a journal of the British Diabetic Association·2019
Same author

Effect of liraglutide on anthropometric measurements, sagittal abdominal diameter and adiponectin levels in people with type 2 diabetes treated with multiple daily insulin injections: evaluations from a randomized trial (MDI-liraglutide study 5).

Obesity science & practice·2019
Same author

Non-insulin treatments for Type 1 diabetes: critical appraisal of the available evidence and insight into future directions.

Diabetic medicine : a journal of the British Diabetic Association·2019
Same author

Blood glucose control using a computer-guided glucose management system in allogeneic hematopoietic cell transplant recipients.

Bone marrow transplantation·2016
Same journal

For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

American family physician·2026
Same journal

Nausea and Vomiting During Pregnancy.

American family physician·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

American family physician·2026
Same journal

Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

American family physician·2026
Same journal

Overscreening Leads to Overdiagnosis of MASLD.

American family physician·2026
Same journal

Type 2 Diabetes: Outpatient Insulin Management.

American family physician·2026
See all related articles

Insulin therapy for diabetes varies by type. Insulin-dependent diabetes requires multiple daily injections or continuous infusion, while non-insulin-dependent diabetes may manage with single daily doses or combination therapies.

Area of Science:

  • Endocrinology and Metabolism
  • Pharmacology of Diabetes Treatment

Background:

  • Insulin is essential for survival in insulin-dependent diabetes mellitus (IDDM).
  • Physiologic insulin delivery requires more than once-daily administration.
  • Non-insulin-dependent diabetes mellitus (NIDDM) patients may require insulin therapy.

Purpose of the Study:

  • To review insulin administration regimens for different diabetes types.
  • To discuss insulin delivery methods for achieving glycemic control.
  • To explore controversial treatment options in NIDDM.

Main Methods:

  • Review of established and emerging insulin delivery strategies.
  • Analysis of insulin regimens for IDDM and NIDDM patients.
  • Discussion of treatment approaches for varying degrees of hyperglycemia.

Related Experiment Videos

Main Results:

  • IDDM necessitates complex insulin regimens, including multiple daily injections or continuous subcutaneous insulin infusion (CSII).
  • NIDDM patients with moderate hyperglycemia may benefit from bedtime intermediate-acting insulin (NPH or ultralente).
  • Severe hyperglycemia in NIDDM requires insulin strategies similar to those for IDDM.

Conclusions:

  • Optimal insulin therapy is tailored to diabetes type and severity.
  • Lifestyle flexibility can be a consideration in choosing insulin regimens.
  • The combination of insulin and sulfonylurea for NIDDM remains a subject of debate.